General Information
BounceWatch is an independent company data service, not affiliated with Cage Pharma. To contact Cage Pharma, visit cagephar.ma.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Cage Pharma compare?
A PDF of Cage Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Cage Pharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Cage Pharma on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Cage Pharma
Business keywords: pre-clinical biopharma, tumor-targeting therapy, cancer treatment, encapsulated formulations, 3-bromopyruvate, tumor metabolism, anti-cancer agent, novel formulation, controlled toxicity profile, Baltimore, Maryland, drug development, biopharmaceutical company
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $137.49K | - |
|
31 May 2024 |
| Seed Round | $480.00K | - |
|
10 Jul 2019 |
| Seed Round | $350.00K | - |
|
05 Jan 2018 |
Cage Pharma Alternatives & Competitors
View All AlternativesPioneering advancements in the fight against high-impact cancers and neurodegenerative diseases with...
Rare Science. Rare Compassion. Rare Solutions.
Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...
FAQ About Cage Pharma
Source: BounceWatch company record for Cage Pharma, https://bouncewatch.com/company/cage-pharma, updated 20 December 2024. When citing, please name BounceWatch and link this page.